Revolutionizing Molecular Analysis

GeneFluidics was incorporated in 2000 to develop a fast, accurate, and simple testing system for improving worldwide health. By integrating novel bionano and microfluidic technologies, the company's revolutionary platform enables complex tests that are normally performed only by skilled technicians in a laboratory to be performed by anyone, anywhere.

Originally conceived as part of a biodefense program, the platform integrates nanotechnology-enabled analyte detection with microfluidic-based automated sample preparation for rapid and accurate 'plug and play' use. For system operation, the user simply introduces a raw sample such as whole blood, urine, saliva, or water to a disposable cartridge, inserts this cartridge into a reader instrument, pushes a button, and waits 10-20 minutes for test results.

Mission Statement: Improve the quality of human life with advanced engineering technologies.

Adobe Reader Required GeneFluidics Overview Brochure

Company Overview:

Management

Dr. Vincent Gau - Co-founder, CEO, President and CTO

Dr. Gau is a recognized international expert on bioMEMS, nanotechnology and microfluidics. He gained extensive high-volume, low-cost manufacturing, and product development experience while he worked for DYNA Image and United Microelectronics Corporation, the second largest integrated circuit foundry in the world. At UMC, Dr. Gau was a Project Leader in charge of managing numerous yield improvement projects and won the 1995 UMC Outstanding Engineer Award. Dr. Gau earned a B.S. in Electrical Engineering from Tamkang University in Taiwan, an M.S. in Electrical Engineering from UCLA, and was the recipient of the first Ph.D. awarded by UCLA in Biomedical Engineering. His Ph.D. simultaneously earned him UCLA's Outstanding Graduate Student and Outstanding Ph.D. awards. Dr. Gau recently received UCLA's prestigious Distinguished Young Alumnus Award.

Directors & Advisors

Dr. Chih-Ming Ho - Chairman of the Board

At UCLA, Dr. Ho currently holds the Ben Rich-Lockheed Martin Professor Chair in the School of Engineering, serves as the Associate Vice Chancellor of Research, and heads the Institute for Cell Mimetic Space Exploration (CMISE) as Director. He is world-renowned for his work in MEMS and microfluidics and is a member or Fellow of numerous honorary societies, including the National Academy of Engineering, the American Physical Society, the American Institute of Aeronautics and Astronautics. He has extensive experience working with startup companies and is currently on the Scientific Advisory Board of Capital Biochip, the largest biochip company in China. Dr. Ho received his B.S. from National Taiwan University and his Ph.D. from Johns Hopkins University.

Mr. Roy Doumani - Director

Mr. Doumani has been the founder, senior executive, and Director of numerous banks and financial institutions, including First Los Angeles Bank, First Interstate Bank of Hawaii (acquired by First Hawaiian Bank), HonFed Bank (acquired by Bank of America), World Trade Bank in Los Angeles (merged into Santa Monica Bank), Gateway Fund, Leader Technology, and the Xiamen International Bank (one of the first banking joint ventures in China). Additionally, Mr. Doumani has served as an Advisor, Director, and principal for biotech companies including Medpay and Agensys. He is a member of the UCLA Board of Governors and the UCLA Campaign Cabinet, in charge of raising $1.2 billion for the University. He currently also serves as the Chief Operating Officer for the UCLA California Nanosystems Institute, a $200MM research institute focusing on the development of bleeding edge nanotechnology.

Dr. Vincent Gau - Director

Dr. AR Frank Wazzan - Director

Dr. Wazzan has served as Director or Advisor to numerous technology companies including Valence Semiconductor, G-Tran, G-Plus, and Maxim Integrated Products, Inc. (Nasdaq-NM:MXIM). He is the former Dean of the School of Engineering and Applied Science (SEAS) at UCLA and is a Professor Emeritus. He is a world authority in nuclear material, thermal hydraulics, and stability of laminar flows and has led major capital raising campaigns for SEAS, raising more than $40MM in 1995 alone. Dr. Wazzan received his BS in Chemical Engineering, MS in Mechanical and Aerospace Engineering, and Ph.D. in Electrical Engineering from UC Berkeley.

Dr. Bryan L. Walser - Director

Dr. Walser was the Vice President of Strategy and Corporate Affairs and a member of the Executive Committee of Chiron Corporation, in Emeryville, California, until its recent acquisition by majority shareholder Novartis AG. Prior to joining Chiron, Dr. Walser was an independent management consultant, working with The Rockefeller Foundation and the Boston Consulting Group on a variety of issues in biotechnology and healthcare, focused on healthcare in the developing world. Before that, Dr. Walser trained in the Emergency Medicine program at UCLA, and worked for several years with the healthcare practice of the Boston Consulting Group. Dr. Walser has served as a Fulbright Fellow studying the pharmaceutical sector in Yogyakarta, Indonesia, and as an International Health Policy Fellow in Basel, Switzerland with F.Hoffmann-La Roche AG. He has published a number of peer-reviewed articles on topics ranging from renal physiology and tropical medicine to international regulatory policy. Dr. Walser earned his undergraduate degree from Stanford, his medical degree from the University of Virginia School of Medicine and his law degree, magna cum laude, from Harvard Law School.

Dr. Edward McCabe - Advisor

Dr. McCabe currently serves as the Executive Chair of the Department of Pediatrics at UCLA Medical School. He is a leading expert in human molecular genetics and was named the chair of the Department of Health and Human Services (HHS)'s Advisory Committee on Genetics, Health, and Society. He developed molecular genetic strategies for the diagnosis of Sickle Cell Disease, Cystic Fibrosis, and Medium Chain Acyl-CoA Dehydrogenase deficiency in newborns and was a pioneer in developing DNA extraction techniques from blood collected on filter paper. Dr. McCabe received his B.S. in Biology from Johns Hopkins University and his Ph.D. and M.D. from the University of Southern California.

Mr. Jerry McGlaughlin - Advisor

Mr. McGlaughlin has been active in the life science industry for over 30 years, beginning in sales for Eli Lilly, Beckman Instruments, Boehringer Mannheim, and Kallestad Diagnostics, before broadening his expertise as a senior executive at Unipath (the medical division of Unilever), Diagnostic Products Corporation, and as the chief executive officer of Biometric Imaging. He has consulted to the medical device, diagnostic, and pharmaceutical industries with his firms McLaughlin & Associates and Great Circle Consulting and currently serves as CEO of CompuMed, a Los Angeles-based clinical diagnostic company.